Posterior Uveitis Associated with Cemiplimab.

Dow ER, Hou K, Ransome S, Abbassi S, Tsui E

DOI: 10.1080/09273948.2021.1872649
Published: 2022 Jul
Container: Ocular immunology and inflammation
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/09273948.2021.1872649,
  title = {Posterior Uveitis Associated with Cemiplimab.},
  author = {Dow ER and Hou K and Ransome S and Abbassi S and Tsui E},
  year = {2022},
  journal = {Ocular immunology and inflammation},
  doi = {10.1080/09273948.2021.1872649},
  url = {https://doi.org/10.1080/09273948.2021.1872649}
}

RIS

TY  - JOUR
TI  - Posterior Uveitis Associated with Cemiplimab.
AU  - Dow ER
AU  - Hou K
AU  - Ransome S
AU  - Abbassi S
AU  - Tsui E
PY  - 2022
JO  - Ocular immunology and inflammation
DO  - 10.1080/09273948.2021.1872649
UR  - https://doi.org/10.1080/09273948.2021.1872649
ER  -

APA

ER, D., K, H., S, R., S, A., & E, T. (2022). Posterior Uveitis Associated with Cemiplimab.. Ocular immunology and inflammation. https://doi.org/10.1080/09273948.2021.1872649

Source records

pubmed · retrieved 2026-09-26T21:52:49.146Z